Sunday, March 8, 2015

Top 10 Cheap Companies To Own For 2015

Top 10 Cheap Companies To Own For 2015: CVS Corporation(CVS)

CVS Caremark Corporation operates as a pharmacy services company in the United States. The company?s Pharmacy Services segment provides a range of pharmacy benefit management services, including mail order pharmacy services, specialty pharmacy services, plan design and administration, formulary management, and claims processing; and drug benefits to eligible beneficiaries under the Federal Government?s Medicare Part D program. This segment primarily serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals. As of December 31, 2010, it operated 44 retail specialty pharmacy stores, 18 specialty mail order pharmacies, and 4 mail service pharmacies located in 25 states, Puerto Rico, and the District of Columbia. This segment operates business under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, CarePlus, RxAmerica, Accordant, and TheraCom names. The company?s Retail Pharmacy segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, seasonal merchandise, greeting cards, and convenience foods through its pharmacy retail stores and online, as well as offers film and photo finishing, and health care services. This segment operated 7,182 retail drugstores located in 41 states, Puerto Rico, and the District of Columbia; and 560 retail health care clinics in 26 states and the District of Columbia under the MinuteClinic name. It has a strategic alliance with Alere, L.L.C. for the management of disease management program offerings that cover chronic diseases, such as asthma, diabetes, congestive heart failure, and coronary artery disease. CVS Caremark Corporation was founded in 1892 and is based in Woonsocket, Rhode Island.

Advisors' Opinion:
  • [By WWW.DAILYFINANCE! .COM]

    Getty Images For all of the things I buy in life, razors seem like the last thing I'd want to buy online. I have a Gillette Mach 3 Turbo razor handle that I bought about 10 years ago, and I buy a 24-pack of razors at Costco (COST) that lasts for a year or more. Yet razors seem to be sold everywhere online. And online sellers are about $1 cheaper per razor than most stores -- unless you find a heck of a sale (as I did at CVS (CVS)) or you shop at a warehouse store such as Costco. But the catch -- and I'm sure the shaving companies set it up this way -- is that you have to own the correct handle, which can cost up to $25. Why does a site such as Dollar Shave Club, with its funny videos, or 800razors, with its plain website, or any other online store sell something that's as easy to get as an impulse buy at the supermarket? Two reasons: Razors aren't as inexpensive as they used to be. And they're locked up behind a theft-proof plexiglass case. Locked Away At the Safeway (SWY) and CVS stores I went to, razors were in case that a clerk must open. You can't just grab a package and head to the checkout. At Safeway, the Gillette razors were locked in a cabinet, behind a counter, along with cigarettes and the baby formula Similac. Apparently, all of these items were shoplifted so often that stores started keeping them under lock and key. That's one less incentive to buy them at your local store. Try finding a store clerk on a busy afternoon to unlock a case of razors -- as if you were buying a tablet or e-book reader at Target (TGT) -- so you can shave. Why Prices Are So High But the bigger reason for the existence of razors online is the same as it is for most things: a lower price. Procter & Gamble's (PG) Gillette owns 76 percent of the shaving market, and Energizer's (ENR) Schick owns 16 percent, says Phil Masiello, founder and CEO of 800razors.com. With such a stranglehold, those companies can charge a premium. "We got into this because we were outraged a

  • [By Shauna O'! Brien]

    Before Tuesday’s opening bell, CVS Health Corp (CVS), which recently changed its name from CVS Caremark, released its third quarter results. Despite lower earnings, the company was able to beat analysts’ expectations. 

    CVS Earnings in Brief

    CVS reported net income of $948 million, or 81 cents per share, down from $1.26 billion, or $1.02 per share, a year ago. Excluding special items, earnings were $1.15 per share – above analysts’ estimate of $1.13 per share. Revenue rose to $35.02 billion from $31.93 billion last year. Analysts expected to see revenue of $34.74 billion. Looking forward, CVS expects to see Q4 earnings between $1.18 and $1.21 per share. Analysts expect to see earnings of $1.21 per share. For FY2014, the company expects to see earnings between $4.47 and $4.50 per share. Analysts expect to see earnings of $4.49 per share.

    CEO Commentary

    President and CEO Larry Merlo commented: “I’m very pleased with our strong results in the third quarter, which reflect better-than-expected revenue growth across the enterprise and expanding retail gross margins. The 2015 PBM selling season continued to be highly successful with a significant number of new business wins across all lines of business.”

    CVS Dividend

    CVS paid its last 27.5 cent dividend on November 3. We expect the company to declare its next quarterly dividend in December. It is likely that the company will boost its dividend in its next payout.

    Stock Performance

    CVS Health Corp shares were up 88 cents, or 1.02%, during pre-market trading Tuesday. The stock is up 20.33% YTD.

    CVS Dividend Snapshot

    As of market close on November 3, 2014

    Click here to see the complete history of CVS dividends.

  • [By Jayson Derrick]

    CVS (NYSE: CVS) reported its third quarter results this morning. The company earned $1.15 per share, beating the consensus estimate of $1.13. Revenue of $35.02 billion beat the consensus! estimate! of $34.73 billion. Shares lost 0.75 percent, closing at $85.47.

  • source from Top Stocks For 2015:http://www.topstocksblog.com/top-10-cheap-companies-to-own-for-2015-2.html

No comments:

Post a Comment